BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Ferro Corporation Appoints Amy McGann Assistant General Counsel and Assistant Secretary

  June 5, 2007

   · 

  1 min read
• Business

  Hutchinson Technology Incorporated Announces Cost Reductions; Actions to Include Elimination of Approximately 500 Positions

  June 5, 2007

   · 

  3 min read
• Biotech Beach

  HealtheUniverse Patented Non-Embryonic Stem Cell Technology in Development for Use in the $15 Billion Plastic, Reconstructive, and Cosmetic Surgery Market

  June 5, 2007

   · 

  1 min read
• Genetown

  Cyberkinetics Neurotechnology Systems, Inc.’ President and Chief Executive Officer Talks Live With MN1

  June 5, 2007

   · 

  1 min read
• Genetown

  Sirtex Medical: Emerging Trends in Radioembolization Using Microspheres: A Clinical Workshop Highlights Latest Research and Data Regarding Treatments for Advanced Liver Tumors

  June 5, 2007

   · 

  1 min read
• Drug Development

  Synta Pharmaceuticals to Host Conference Call Today

  June 5, 2007

   · 

  1 min read
• Drug Development

  Abraxis BioScience, Inc. Release: New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treatment of Lung and Ovarian Cancers

  June 5, 2007

   · 

  7 min read
• Biotech Beach

  EBD Group: Medtech, Biotech and Pharma Industry Leaders Converge in Zurich for Second Annual BioDevice Partnering Conference, June 12-13, 2007

  June 5, 2007

   · 

  1 min read
• Policy

  Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company ABILIFY(R) (aripiprazole) Supplemental New Drug Application for Pediatric Patients With Schizophrenia Accepted for Priority Review by the U.S. FDA

  June 5, 2007

   · 

  9 min read
• Biotech Beach

  Metagenics Inc.'s Medical Food with Select Kinase Response Modulators (SKRMs) Has Powerful Effect on Metabolic Syndrome, Study Says

  June 5, 2007

   · 

  1 min read